Elevation Oncology, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$0.22 | -$0.22 | -$0.22 |
| Q2 2024 | 5 | -$0.20 | -$0.19 | -$0.19 |
| Q3 2024 | 3 | -$0.20 | -$0.20 | -$0.20 |
| Q1 2025 | 4 | -$0.19 | -$0.19 | -$0.19 |
| Q2 2025 | 4 | -$0.20 | -$0.20 | -$0.20 |
| Q3 2025 | 4 | -$0.21 | -$0.21 | -$0.21 |
| Q4 2025 | 4 | -$0.21 | -$0.21 | -$0.21 |
Elevation Oncology, Inc. Earnings Date And Information
Elevation Oncology, Inc. last posted its earnings results on Tuesday, August 6th, 2024. The company reported $-0.18 earnings per share for the quarter, topping analysts' consensus estimates of $-0.23 by $0.05. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Elevation Oncology, Inc. has generated $-1 earnings per share over the last year ($-1.34 diluted earnings per share) and currently has a price-to-earnings ratio of -0.78. Elevation Oncology, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 4th, 2024 based on prior year's report dates.
Elevation Oncology, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/06/2024 | Q2 2024 | -$0.23 | -$0.18 | 0.05 | $0 | $0 |
| 05/02/2024 | Q1 2024 | -$0.21 | -$0.23 | -0.02 | $0 | |
| 03/06/2024 | Q4 2023 | -$0.21 | -$0.19 | 0.02 | $58,000 | |
| 11/02/2023 | Q3 2023 | -$0.34 | -$0.25 | 0.09 | $0 | |
| 08/03/2023 | Q2 2023 | -$0.28 | -$0.37 | -0.09 | $0 | |
| 05/15/2023 | Q1 2023 | -$0.51 | -$0.72 | -0.21 | $0 | |
| 03/09/2023 | Q4 2022 | -$0.67 | -$0.82 | -0.15 | $0 | |
| 11/03/2022 | Q3 2022 | -$1.12 | -$1.68 | -0.56 | $0 | |
| 08/04/2022 | Q2 2022 | -$0.80 | -$0.85 | -0.05 | $0 | |
| 05/05/2022 | Q1 2022 | -$0.51 | -$0.74 | -0.23 | $0 | |
| 03/03/2022 | Q4 2021 | -$0.59 | -$0.79 | -0.2 | $0 | |
| 11/12/2021 | Q3 2021 | -$0.35 | -$0.53 | -0.18 | $0 | |
| 08/12/2021 | Q2 2021 | -$2.82 | -$4.84 | -2.02 | $0 | |
| 03/31/2021 | Q1 2021 | -$0.22 | $0 | |||
| 12/31/2020 | Q4 2020 | -$0.54 | $0 | |||
| 09/30/2020 | Q3 2020 | -$0.18 | $0 | |||
| 06/30/2020 | Q2 2020 | -$0.21 | $0 | |||
| 03/31/2020 | Q1 2020 | -$0.12 | $0 |
Elevation Oncology, Inc. Earnings: Frequently Asked Questions
-
When is Elevation Oncology, Inc.'s earnings date?
Elevation Oncology, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 4th, 2024 based off last year's report dates.
-
Did Elevation Oncology, Inc. beat their earnings estimates last quarter?
In the previous quarter, Elevation Oncology, Inc. (:ELEV) reported $-0.18 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.23 by $0.05.
-
How can I listen to Elevation Oncology, Inc.'s earnings conference call?
The conference call for Elevation Oncology, Inc.'s latest earnings report can be listened to online.
-
How can I read Elevation Oncology, Inc.'s conference call transcript?
The conference call transcript for Elevation Oncology, Inc.'s latest earnings report can be read online.
-
How much profit does Elevation Oncology, Inc. generate each year?
Elevation Oncology, Inc. (:ELEV) has a recorded net income of $0. Elevation Oncology, Inc. has generated $-1.34 earnings per share over the last four quarters.
-
What is Elevation Oncology, Inc.'s price-to-earnings ratio?
Elevation Oncology, Inc. (:ELEV) has a price-to-earnings ratio of -0.78 and price/earnings-to-growth ratio is -0.04.
